opendata.bot
Company number
02575564

SELECTIVE ANTIBODIES LIMITED

Active
✓ Active company on the official register. Next accounts due 31 August 2027.

Company details

Registered name
SELECTIVE ANTIBODIES LIMITED
Company number
02575564
Registered office
2 GOSFORTH PARK AVENUE, NEWCASTLE UPON TYNE, NE12 8EG, ENGLAND
Company type
Private Limited Company
Incorporated on
21 January 1991
Status
Active
Age
35 years
Nature of business (SIC)
72110 — Research and experimental development on biotechnology
Accounts — next due
31 Aug 2027
Accounts — last made up to
30 Nov 2025
Confirmation statement — next due
05 Nov 2026
Confirmation statement — last
22 Oct 2025

What the register says

Facts from the register, with the dates they are filed under. Not a score: what they mean is for you to judge, and every line can be checked against Companies House itself.

Companies House register snapshot, read 02/09/2026.

People with significant control

Beneficial owners holding over 25% of shares, voting rights or the right to appoint directors

Professor Colin Henry Self
ownership-of-shares-50-to-75-percent, voting-rights-50-to-75-percent
Notified 06/04/2016

Corporate structure

Who controls this company, and who they control in turn

1 controller Drag to move · scroll to zoom · double-click to expand
Company Person Current control Ended

Connections

Professor Colin Henry Self
born 01/1944 · England owns 50–75% of shares · holds 50–75% of votes Notified 06/04/2016 Controls 2 companies

Change history

Reconstructed from the dated records Companies House publishes

DateChangeWasNow
06/04/2016 Person with significant control added Professor Colin Henry Self

Documents for SELECTIVE ANTIBODIES LIMITED

Need this one company on file? Buy the document on its own — no plan required.

Company extract£1.99

The full registration record as held today — name, number, status, registered office, company type, previous names, officers, PSC and SIC codes, timestamped for your file.

PDF Order
Financial statements£3.99

Every figure the company’s own accounts state, across each filed period, with year-on-year movement. Most UK companies file small or micro-entity accounts — a balance sheet and a headcount, no turnover or profit.

PDF + CSV Order
Ownership report£3.99

Who controls the company: persons with significant control, the nature of that control, the ownership graph and every other company those controllers hold.

PDF Order

Data protection register

Registered with the Information Commissioner's Office as a data protection fee payer.

SELECTIVE ANTIBODIES LIMITED — TN13 1XJ
Tier 1 · renews 29/07/2027
ICO entry

The ICO publishes no company number, so this is matched on the registered name . Check the ICO entry before relying on it.

Get this company via API

Every field on this page is available as structured JSON behind one endpoint and one API key.

GET /v1/company/gb/02575564
X-Api-Key: $OPENDATA_KEY
Read the API docs

Frequently asked questions

What is the company number of SELECTIVE ANTIBODIES LIMITED?
According to the official registry, the company number of SELECTIVE ANTIBODIES LIMITED is 02575564.
Where is SELECTIVE ANTIBODIES LIMITED registered?
The registered office is 2 GOSFORTH PARK AVENUE, NEWCASTLE UPON TYNE, NE12 8EG, ENGLAND.
What is the SIC code of SELECTIVE ANTIBODIES LIMITED?
The nature of business is recorded under SIC code 72110 — Research and experimental development on biotechnology.
Who controls SELECTIVE ANTIBODIES LIMITED?
Professor Colin Henry Self is recorded as a person with significant control, with ownership of shares 50 to 75 percent, voting rights 50 to 75 percent.
When are the next accounts of SELECTIVE ANTIBODIES LIMITED due?
The next annual accounts are due by 31 August 2027, and the last accounts were made up to 30 November 2025.

About SELECTIVE ANTIBODIES LIMITED (02575564)

SELECTIVE ANTIBODIES LIMITED is a private limited company incorporated on 21 January 1991 and registered in the United Kingdom under company number 02575564. Its registered office is at 2 GOSFORTH PARK AVENUE, NEWCASTLE UPON TYNE, NE12 8EG, ENGLAND. The recorded nature of business is research and experimental development on biotechnology (SIC 72110). The company is currently active , with statutory accounts last made up to 30 November 2025. , and the person with significant control is Professor Colin Henry Self. This profile is provided by opendata.bot by Noetikos, aggregating official data from Companies House bulk data , last refreshed 2 September 2026.

Companies at the same registered office

Research and experimental development on biotechnology across UK registers

The same sector and the same company, seen through every register we hold

Explore by sector

Every UK company records what it does as a SIC code — browse the sectors around this one.